| Primary |
| Asthma |
44.4% |
| Multiple Allergies |
33.3% |
| Hypersensitivity |
11.1% |
| Status Asthmaticus |
11.1% |
|
| Troponin Increased |
25.0% |
| Drug Hypersensitivity |
12.5% |
| Dyspnoea |
12.5% |
| Pharmaceutical Product Complaint |
12.5% |
| Pulmonary Haemorrhage |
12.5% |
| Stress Cardiomyopathy |
12.5% |
| Vision Blurred |
12.5% |
|
| Secondary |
| Asthma |
36.0% |
| Product Used For Unknown Indication |
9.9% |
| Drug Use For Unknown Indication |
7.2% |
| Chronic Obstructive Pulmonary Disease |
6.3% |
| Anxiety |
4.5% |
| Osteoporosis |
3.6% |
| Panic Attack |
3.6% |
| Arthralgia |
2.7% |
| Back Pain |
2.7% |
| Depression |
2.7% |
| Gastrooesophageal Reflux Disease |
2.7% |
| Musculoskeletal Pain |
2.7% |
| Pain In Extremity |
2.7% |
| Acute Sinusitis |
1.8% |
| Bronchitis Acute |
1.8% |
| Hypertension |
1.8% |
| Hypothyroidism |
1.8% |
| Osteoarthritis |
1.8% |
| Post-traumatic Stress Disorder |
1.8% |
| Synovial Cyst |
1.8% |
|
| White Blood Cell Count Increased |
11.1% |
| Drug Interaction |
7.4% |
| Epidural Lipomatosis |
7.4% |
| Lower Respiratory Tract Infection |
7.4% |
| Pain |
7.4% |
| Vanishing Twin Syndrome |
7.4% |
| Back Pain |
3.7% |
| Death |
3.7% |
| Drug Ineffective |
3.7% |
| Exposure During Pregnancy |
3.7% |
| Feeling Abnormal |
3.7% |
| Hyperhidrosis |
3.7% |
| Hypermetropia |
3.7% |
| Leukocytoclastic Vasculitis |
3.7% |
| Oropharyngeal Pain |
3.7% |
| Pruritus |
3.7% |
| Rash Erythematous |
3.7% |
| Scab |
3.7% |
| Stress Cardiomyopathy |
3.7% |
| Tremor |
3.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
25.8% |
| Asthma |
13.2% |
| Product Used For Unknown Indication |
12.5% |
| Rheumatoid Arthritis |
7.8% |
| Pain |
5.4% |
| Chronic Obstructive Pulmonary Disease |
4.6% |
| Hypertension |
3.9% |
| Bronchopulmonary Dysplasia |
2.5% |
| Crohn's Disease |
2.5% |
| Non-small Cell Lung Cancer |
2.4% |
| Osteoarthritis |
2.3% |
| Depression |
2.2% |
| Hiv Infection |
2.2% |
| Smoking Cessation Therapy |
2.1% |
| Bronchitis |
2.0% |
| Diabetes Mellitus |
2.0% |
| Hypersensitivity |
1.9% |
| Pneumonia |
1.9% |
| Gastrooesophageal Reflux Disease |
1.6% |
| Prophylaxis |
1.5% |
|
| Pneumonia |
10.9% |
| Urinary Tract Infection |
7.0% |
| Weight Increased |
7.0% |
| Accidental Exposure |
6.3% |
| Respiratory Failure |
6.3% |
| Vomiting |
6.3% |
| Weight Decreased |
5.5% |
| White Blood Cell Count Increased |
5.5% |
| Sinusitis |
4.7% |
| Vasculitis |
4.7% |
| Ventricular Fibrillation |
4.7% |
| Myocardial Infarction |
3.9% |
| Shock |
3.9% |
| Syncope |
3.9% |
| Tremor |
3.9% |
| Death |
3.1% |
| Incorrect Dose Administered |
3.1% |
| Malaise |
3.1% |
| Pain |
3.1% |
| Pyrexia |
3.1% |
|
| Interacting |
| Asthma |
71.4% |
| Smoking Cessation Therapy |
28.6% |
|
|
